四环医药(00460.HK)9月26日回购150万股 总金额约222万港元

Core Viewpoint - The company, 四环医药 (Sihuan Pharmaceutical), has announced a share buyback program, purchasing a total of 1.5 million shares at an average price of HKD 1.48 per share, which reflects a strategic move to manage its capital structure and potentially enhance shareholder value [1] Group 1 - The total purchase price for the repurchased shares is approximately HKD 2.22 million, excluding commissions and other expenses [1] - The repurchased shares account for about 0.0163% of the company's total issued shares, excluding treasury shares [1] - The company plans to hold the repurchased shares as treasury stock for future sale or transfer [1]